illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Aarti Pharmalabs
Company logo

Aarti Pharmalabs | Sustainability Performance

https://www.aartipharmalabs.com
Linkedin

Manufactures active pharmaceutical ingredients, intermediates, xanthine derivatives and CDMO services.

2019

India

1,001 - 5,000 employees

Pharmaceuticals

$100M - 500M in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#1572
Overall
#32
in India
#44
in Pharmaceuticals

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

123 out of 312

Overview
Governance
TargetsESG scores and exclusions
Financial Data
Business performanceCapital & innovation

View similiar companies


Company logo
RPG Life Sciences

India, Hospital & Health Care, Pharmaceuticals


Company logo
Solara Active Pharma Sciences

India, Hospital & Health Care, Pharmaceuticals


Company logo
Ipca Laboratories

India, Hospital & Health Care, Pharmaceuticals

Market cap

1.0B $, 2026▲9.6% YoY

Revenue

250.0M $, 2026

R&D intensity

1.8% 2026

Market cap

1.0B $, 2026▲9.6% YoY

Revenue

250.0M $, FY2026▼NaN% YoY

EBITDA

34.2M $, FY2026▼9.1% YoY

Operating margin

16% Industry: -631▼8.9% YoY

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-12.9M 2025▲115.6% YoY

Capex

50.9M 2025▲55.2% YoY

Debt/equity ratio

0.4 Industry: 0▼NaN% YoY

R&D intensity

1.8%FY2026

R&D as % of revenue

R&D as % of revenue
Industry benchmark

Powered by illuminem

Return on invested capital

6.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

30%
Independent Directors

3 out of 10 incl. management

Powered by illuminem

SBTi targets and commitments

TargetStatusTemperature alignmentYear
Near-term targetTargets set1.5°CFY2029
Long-term targetTargets set1.5°CFY2049
Net-zeroTargets set-2050
Business Ambition 1.5°CNot disclosed--

Target details

Overall Net-Zero Target: Aarti Pharmalabs Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Aarti PharmaLabs Limited commits to reduce absolute scope 1 and 2 GHG emissions 37.8% by FY2030 from a FY2024 base year.* Aarti PharmaLabs Limited also commits to reduce absolute scope 3 GHG emissions 22.5% within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: Aarti Pharmalabs Limited commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2050 from a FY2024 base year.* Aarti Pharmalabs Limited also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks.

Powered by illuminem and Science Based Targets initiative. Last updated: 17 Apr 2025

Sustainability targets and commitments

TargetYearValueScopeBaseline

Overall score

0

Environment

0

Social

0

Governance

0

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

Not reporting on Sustainability


image report
Available
image report
Available

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email